Systematic review estimates the prevalence of mutations in upper tract urothelial carcinoma, suggesting the need for targeted testing.
LS prevalence among patients with UTUC is similar to that among patients with colorectal and endometrial cancers, which provides a strong rationale for LS testing in this population. Further research is necessary to determine the optimal diagnostic strategy.
No takes yet. Share an insight, caveat, or question.
Moryousef et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: